Category Matches
- 0.1 mg
- 1 g
- 1 kg
- 1 kit
- 1 L
- 1 mg
- 1 ml
- 1 MU
- 1 Plate
- 1 µg
- 10 g
- 10 mg
- 10 ml
- 10 µg
- 100 g
- 100 mg
- 100 mh
- 100 ml
- 100 Tests
- 100 µg
- 100-200 Tests
- 1000 g
- 100g
- 11β-HSD Inhibitor
- 125 mg
- 125 Tests
- 1mg
- 2-BHA
- 2BHA
- 5 x 100 µg
- 5-a-reductase Inhibitors
- 5-HT1 Receptors - Analgesics
- 5-HT1 Receptors - Antidepressant
- 5-HT1 Receptors - Antipsychotic
- 5-HT1 Receptors - Anxiolytic
- 5-HT1 Receptors - Cognition Enhancing
- 5-HT1 Receptors - Hypnotics
- 5-HT1 Receptors - Sedatives
- 5-HT2 Receptors - Analgesics
- 5-HT2 Receptors - Antidepressant
- 5-HT2 Receptors - Antipsychotic
- 5-HT2 Receptors - Anxiolytic
- 5-HT2 Receptors - Cognition Enhancing
- 5-HT2 Receptors - Hypnotics
- 5-HT2 Receptors - Neurodegenerative Diseases
- 5-HT2 Receptors - Sedatives
- 5-HT3 Receptors - Analgesics
- 5-HT3 Receptors - Antidepressant
- 5-HT3 Receptors - Antipsychotic
- 5-HT3 Receptors - Anxiolytic
- 5-HT3 Receptors - Cognition Enhancing
- 5-HT3 Receptors - Hypnotics
- 5-HT3 Receptors - Sedatives
- 5-HT5 Receptors - Analgesics
- 5-HT5 Receptors - Antidepressant
- 5-HT5 Receptors - Antipsychotic
- 5-HT5 Receptors - Anxiolytic
- 5-HT5 Receptors - Cognition Enhancing
- 5-HT5 Receptors - Neurodegenerative Diseases
- 5-HT5 Receptors - Sedatives
- 5-HT6 Receptors - Analgesics
- 5-HT6 Receptors - Antidepressant
- 5-HT6 Receptors - Antipsychotic
- 5-HT6 Receptors - Anxiolytic
- 5-HT6 Receptors - Cognition Enhancing
- 5-HT6 Receptors - Neurodegenerative Diseases
- 5-HT6 Receptors - Sedatives
- 5-HT7 Receptors - Analgesics
- 5-HT7 Receptors - Antidepressant
- 5-HT7 Receptors - Antipsychotic
- 5-HT7 Receptors - Anxiolytic
- 5-HT7 Receptors - Cognition Enhancing
- 5-HT7 Receptors - Sedatives
- 5-Lipoxygenase Inhibitors
- 5-α-Reductase Inhibitors
- 50-100 Tests
- 6-hydroxydopamine
- 6-OHDA
- a-Glucosidase Inhibitors
- ACE Inhibitors
- acetoxychaviol
- Acetyl-CoA Carboxylase Inhibitor
- AChE - Cognition Enhancing
- AChE - Neurodegenerative Diseases
- ACP-196
- ACP196
- ACTH Agonists
- Adenosine Antagonists (Xanthines)
- Adenosine Receptors - Cognition Enhancing
- Adrenal Hormones and Modulators
- Adrenergic Receptors - Anesthetic
- Adrenergic Receptors - Antipsychotic
- Adrenergic Receptors - Cognition Enhancing
- Adrenergic Receptors - Hypnotics
- adu-s100
- adus100
- Aldosterone Antagonists - Antihypertensive
- alpha-zearalanol
- alpha-zearalenol
- Alzheimer's
- Alzheimer's Disease
- Alzheimer's Disease
- AMPA - Antipsychotic
- AMPA - Cognition Enhancing
- amphenicols
- Amphibian peptides and Hormones
- AMPK - Cognition Enhancing
- Amyotrophic Lateral Sclerosis
- Androgen Synthesis Inhibitors
- andrographolide
- Anesthetic
- Angiotensin II Inhibitors
- Anthraquinone
- Anti-arrhythmic
- Anti-arthritics
- Anti-asthma
- Anti-atherosclerotic
- Anticholinergics
- Antihistamines
- Antihistamines - Therapies for Respiratory Diseases and Allergy Management
- Antihyperlipidemics
- Antihypertensive
- Antimicrobial Peptides - Others
- Antipsychotic
- Antithrombotic
- Aromatase Inhibitors - Anticancer
- Aromatase Inhibitors - Immunology
- artemether
- Arthropod peptides and Hormones
- AT-7519
- AT7519
- AZ-5104
- AZ5104
- AZD-1152
- AZD-1152-HQPA
- AZD-1208
- AZD-8186
- AZD-9291
- BACE1
- BAY1816032
- BChE - Cognition Enhancing
- BChE - Neurodegenerative Diseases
- BHA
- Biochemicals
- Bisphosphonates
- BIX01294
- BUB1
- BYL719
- Ca2+ Channel Blockers - Anti-anginal
- Ca2+ Channel Blockers - Antihypertensive
- Ca2+ Channel Blockers - Vasodilatory
- Ca2+ Channels - Analgesics
- Ca2+ Channels - Anesthetic
- Ca2+ Channels - Antidepressant
- Ca2+ Channels - Antiepileptics and Anticonvulsants
- Ca2+ Channels - Antipsychotic
- Ca2+ Channels - Anxiolytic
- Ca2+ Channels - Cognition Enhancing
- Ca2+ Channels - Sedatives
- Ca2+ Ion Channels - Neurodegenerative Diseases
- catechin
- catharanthine
- CCK Release Inhibitors
- CEP-28122
- cephalosporins
- chemicals for COVID-19 research
- Chemopreventive
- CHIR99021
- Chk1/2
- Chloramphenicol
- Chloroquine
- cholesterol
- Class I (Na+ Channel Blocker)
- Class III (K+ Channel Blocker)
- Class IV (Ca2+ Channel Blocker)
- Class V (Other)
- cochliobolin
- Cognition Enhancing
- colchicine
- Compounds targeting DNA synthesis and repair
- Cough Management
- COVID-19
- covid-19
- COVID-19 chemicals
- COVID-19 compounds
- COX-1 - Analgesics
- cryptotanshinone
- cyclohexylmethylguanine
- CYP17A1 Inhibitors
- D-amino Acid Oxidase - Antipsychotic
- D1 Receptors - Analgesics
- D1 Receptors - Anesthetic
- D1 Receptors - Antidepressant
- D1 Receptors - Antipsychotic
- D1 Receptors - Anxiolytic
- D1 Receptors - Cognition Enhancing
- D1 Receptors - Neurodegenerative Diseases
- D1 Receptors - Sedatives
- D2 Receptors - Anesthetic
- D2 Receptors - Antipsychotic
- D2 Receptors - Cognition Enhancing
- D3 Receptors - Antipsychotic
- D3 Receptors - Cognition Enhancing
- D4 Receptors - Antipsychotic
- D4 Receptors - Cognition Enhancing
- D5 Receptors - Antipsychotic
- D5 Receptors - Cognition Enhancing
- DA Receptor Signaling - Anesthetic
- DA Receptor Signaling - Antipsychotic
- DA Receptor Signaling - Cognition Enhancing
- dexamethasone
- dexamethasone
- dextromethorphan
- dihydroartemisinin
- Dihydrofolate Reductase
- Dihydrofolate Reductase Inhibitors
- DNA and RNA Synthesis Inhibitors
- DNA Methyltransferase
- Dopamine Receptor Inhibitors
- dorsomorphin
- DOT1L Histone Methyltransferase
- DPP-4 Inhibitors
- Eicosanoid Inhibitors
- eidd-1931
- EIDD-2801
- EIDD2801
- eIF2B - Cognition Enhancing
- Endothelin Receptor Antagonists
- ephR
- epicatechin
- epicatechin gallate
- epigallocatechin
- epigallocatechin gallate
- Epinephrine/NE Agonists
- Ergosterol Inhibitors
- Estrogen Receptor Inhibitors
- exclude-from-search
- EZH2 Histone Methyltransferase
- Factor Xa Inhibitors
- Furans - Other nucleic acid inhibitors
- GABA - Anesthetic
- GABA - Antipsychotic
- GABA - Cognition Enhancing
- gallacatechin
- gallocatechin
- Gastric Inhibitory Peptide
- GBR-12935
- GDC-0941
- Ghrelin Agonists
- GHRH Agonists
- Ginkgolides and other Ginkgo-related Compounds
- Ginsenosides and Other Ginseng-related Compounds
- GLP-1 Agonists
- Glucocorticoids - Other Therapies
- Glycyrrhetinic Acid
- Glycyrrhizic Acid
- Glycyrrhizin
- GlyR - Anesthetic
- GnRH Agonists
- GSK-3 - Cognition Enhancing
- guanine nucleotide exchange factor
- Gut/Gastrointestinal Hormones
- H-89
- Haloperidol
- HDAC inhibitor
- herbimycin
- hesperidin
- HEXIM1
- HIF-1
- Histamine Receptors - Analgesics
- Histamine Receptors - Antidepressant
- Histamine Receptors - Antipsychotic
- Histamine Receptors - Anxiolytic
- Histamine Receptors - Cognition Enhancing
- Histamine Receptors - Hypnotics
- Histamine Receptors - Neurodegenerative Diseases
- Histamine Receptors - Sedatives
- Histone Deacetylase
- HIV
- HMG-CoA Reductase Inhibitors (Statins)
- Hormone Receptor Modulators
- Hs578T
- Hs578Ts(i)8
- HSP70
- HSP90
- huntington's
- huperzine
- hydrocortisone
- hydrocortisone
- hydroxychloroquine
- Hypnotics
- hypoerphosphorylated tau
- Hypothalamic-Pituitary Hormones
- hypoxia
- IGF-1R
- Imidazoline Receptors - Antipsychotic
- Imidazoline Receptors - Cognition Enhancing
- IMPDH
- Indomethacin
- Inhibitors of other enzymes
- Integrase Inhibitors
- Ion Channels - Analgesics
- Ion Channels - Anesthetic
- Ion channels - Antidepressant
- Ion Channels - Antiepileptics and Anticonvulsants
- Ion Channels - Antipsychotic
- Ion Channels - Anxiolytic
- Ion Channels - Cognition Enhancing
- Ion Channels - Hypnotics
- Ion Channels - Neurodegenerative Diseases
- Ion Channels - Sedatives
- ionophores
- Isothiocyanate
- JQ-1
- JQ-1
- K+ ATP Channel Blockers
- K+ Channels - Analgesics
- K+ Channels - Anesthetic
- K+ Channels - Antidepressant
- K+ Channels - Antiepileptics and Anticonvulsants
- K+ Channels - Antipsychotic
- K+ Channels - Anxiolytic
- K+ Channels - Cognition Enhancing
- K+ Channels - Hypnotics
- K+ Channels - Sedatives
- K+ Ion Channels - Neurodegenerative Diseases
- kashin-beck
- Kinesin Inhibitors
- KNL1
- Kynurenine 3-hydroxylase - Neurodegenerative Diseases
- LOXO-195
- loxo195
- M2 Protein Inhibitors
- mAChR - Analgesics
- mAChR - Anesthetic
- mAChR - Antidepressant
- mAChR - Antipsychotic
- mAChR - Anxiolytic
- mAChR - Cognition Enhancing
- mAChR - Hypnotics
- mAChR - Neurodegenerative Diseases
- mAChR - Sedatives
- MCH Agonists
- Melanin-CH
- Melanocyte Stimulating Hormone
- Melatonin Receptors - Hypnotics
- menthol
- Metabolic and GI Pathology
- methotrexate
- methylprednisolone
- mGluR - Cognition Enhancing
- Microtubule Polymerization/Depolymerization Inhibitors
- MSH Agonists
- Muscarininc Acetylcholine Receptor Inhibitors
- Mycophenolic Acid
- mycophenolic acid
- N-Arylanthranilic acid Derivatives (Fenamates)
- Na+ Channels - Analgesics
- Na+ Channels - Anesthetic
- Na+ Channels - Antidepressant
- Na+ Channels - Antiepileptics and Anticonvulsants
- Na+ Channels - Antipsychotic
- Na+ Channels - Anxiolytic
- Na+ Channels - Cognition Enhancing
- Na+ Channels - Sedatives
- Na+ Ion Channels - Neurodegenerative Diseases
- nAChR
- nAChR - Analgesics
- nAChR - Anesthetic
- nAChR - Antidepressant
- nAChR - Antiepileptics and Anticonvulsants
- nAChR - Anxiolytic
- nAChR - Cognition Enhancing
- nAChR - Neurodegenerative Diseases
- nAChR - Sedatives
- Naphthoquinone
- NCCT Inhibitors (Thiazide/Thiazide-like diuretics)
- NET - Antipsychotic
- NET - Hypnotics
- Neuraminidase Inhibitors
- NKCC1 Inhibitors (Loop Diuretics)
- NMDA - Anesthetic
- NMDA - Antipsychotic
- NMDA - Cognition Enhancing
- NSAIDs: COX-1 Inhibitors
- NSAIDs: COX-2 Inhibitors
- OHDA
- ophiobolin A
- Opioid Receptors - Anesthetic
- Opioid Receptors - Cognition Enhancing
- Other Analogs
- Other Compounds
- Other DA Signaling - Analgesics
- Other DA Signaling - Anesthetic
- Other DA Signaling - Antidepressant
- Other DA Signaling - Antipsychotic
- Other DA Signaling - Anxiolytic
- Other DA Signaling - Cognition Enhancing
- Other DA Signaling - Neurodegenerative Diseases
- Other DA Signaling - Sedatives
- Other Diuretics
- Other Hormones and Modulators
- Other Ion Channels - Analgesics
- Other Ion Channels - Anesthetic
- Other Ion Channels - Antidepressant
- Other Ion Channels - Antiepileptics and Anticonvulsants
- Other Ion Channels - Antipsychotic
- Other Ion Channels - Anxiolytic
- Other Ion Channels - Cognition Enhancing
- Other Ion Channels - Sedatives
- Other Lipid-lowering Compounds
- Other Neurotransmitters
- Other NSAID
- Other Nucleic Acid Inhibitors
- Other Products
- Other Targets
- Other Therapies
- Others
- Others - Antibacterial
- Others - Antidiabetic
- Others - Antithrombotic
- Others - Cell Membrane Modifiers
- Others - Ergosterol Inhibitors
- Others - Other nucleic acid inhibitors
- OTX-015
- p110
- p110alpha
- P2Y12
- Parathyroid Hormone Agonists
- parthenolide
- PDK1
- PF-07321332
- Pharmaceutical Impurities and Derivatives
- Pharmaceutical Impurities and Derivatives
- Phytoestrogens
- phytosterol
- Pim-1
- Pim1
- PKC412
- polyphenol
- Prostaglandin D Synthase Inhibitors
- Prostaglandin Synthetase - Analgesics
- Protease Inhibitors
- Protein Arginine Methyltransferase
- Protein synthesis Inhibitors
- Proton Pump Inhibitors
- quinghaosu
- Rac1
- RAD51
- rated-1
- Renin Inhibitors
- Reverse Transcriptase Inhibitors
- RN-1734
- ROS1
- SB-431542
- Sedatives and Hypnotics
- ser910
- Serine/Threonine Kinase Inhibitors
- Serotonin (5-HT3) Receptor Inhibitors
- Serotonin Receptors - Antipsychotic
- Serotonin Receptors - Cognition Enhancing
- Serotonin Receptors - Hypnotics
- SERT - Antipsychotic
- SERT - Cognition Enhancing
- SERT - Hypnotics
- Sigma Receptors - Antipsychotic
- Sigma Receptors - Cognition Enhancing
- Steroids Hormones and Modulators
- su9516
- synephrine
- T315i
- Tachykinin
- TAK-931
- Tetrahydropyrimidines
- tetrahydroquinoline
- Therapies for Respiratory Diseases and Allergy Management
- Thiazoles
- thiazolidinedione
- thiocyanate
- thioguanine
- thiolutin
- Thioredoxin Reductase
- thioridazine
- Thrombin Inhibitors
- Thromboxane Receptor Antagonists
- Thymidine
- Thymidine/Thymine
- Thymidylate Synthase
- Thymopoietin/Thymopentin Agonists
- Thymosin Agonists
- Thymulin Agonists
- Thyroid Hormone Agonists
- Thyroid Hormones and Modulators
- Thyrotropin-RH
- Topoisomerase Inhibitors
- trehalose
- TRH Agonists
- Trk Receptors - Cognition Enhancing
- TRP Channels - Analgesics
- TRP Channels - Anesthetic
- TRP Channels - Antidepressant
- TRP Channels - Antiepileptics and Anticonvulsants
- TRP Channels - Antipsychotic
- TRP Channels - Anxiolytic
- TRP Channels - Cognition Enhancing
- TRP Channels - Neurodegenerative Diseases
- TRP Channels - Sedatives
- tryptophan
- Tubulin Inhibitors
- Tyrosine Kinase Inhibitors
- UNC0064-12
- USP40 Taxol Impurities - Semisynthetic
- VE821
- Viral Fusion and Entry Inhibitors
- xanthene
- α1-adrenergic Receptor Antagonists - Antihypertensive
- α1-adrenergic Receptor Antagonists - Vasodilatory
- β-Glucan Synthase Inhibitors (echinocandins)
- β-lactamase inhibitors
Product Matches
Product ID
Name
Description
Purity
- Six New Products for the New YearLKT Labs continues to expand its catalog with six new compounds for the new year...
- Oxytocin Innovations and an FDA-approved Peptide DatabasePeptides and proteins as therapeutics have the advantage over other drugs of usi...
- Catalog RequestThe 2016-18 LKT Labs catalog contains close to 3,000 small molecules and peptide...
- Product FlyersBelow are many of the promotional flyers, you can select the one you want or you...
- Terms and ConditionsLKT Laboratories Inc. is focused on the production and distribution of high puri...
- Bulk Quote RequestLKT Labs offers discounting for bulk orders. We frequently provide small molecul...